Literature DB >> 12614034

Dry eye syndromes: diagnosis, clinical trials and pharmaceutical treatment--'improving clinical trials'.

M B Abelson1, G W Ousler, L A Nally, T B Emory.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12614034     DOI: 10.1007/978-1-4615-0717-8_152

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  3 in total

1.  Effectiveness of dry eye therapy under conditions of environmental stress.

Authors:  Alan Tomlinson; Louise C Madden; Peter A Simmons
Journal:  Curr Eye Res       Date:  2013-01-07       Impact factor: 2.424

2.  Dry Eye Signs and Symptoms Persist During Systemic Neutralization of IL-1β by Canakinumab or IL-17A by Secukinumab.

Authors:  Cynthia L Grosskreutz; Hans-Ulrich Hockey; Denise Serra; Thaddeus P Dryja
Journal:  Cornea       Date:  2015-12       Impact factor: 2.651

Review 3.  Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review.

Authors:  George W Ousler; David Rimmer; Lisa M Smith; Mark B Abelson
Journal:  Ophthalmol Ther       Date:  2017-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.